Pfizer (PFE) Shares Outstanding (Diluted Average) (2009 - 2026)

Pfizer (PFE) has 17 years of Shares Outstanding (Diluted Average) data on file, last reported at $5.7 billion in Q1 2026.

• Shares Outstanding (Diluted Average) for Q1 2026 came in at $5.7 billion, changed 0.37% year-over-year; the trailing twelve-month figure through Mar 2026 was $5.7 billion (changed 0.37% YoY), and the FY2025 annual result was $5.7 billion, changed 0.23% from the prior year.
• Shares Outstanding (Diluted Average) was little changed at $5.7 billion in Q1 2026 per PFE's latest filing, from $5.7 billion in the prior quarter.
• Over five years, Shares Outstanding (Diluted Average) peaked at $5.8 billion in Q2 2022 and troughed at $5.6 billion in Q4 2023.
• A 5-year average of $5.7 billion and a median of $5.7 billion in 2025 frame the typical range for Shares Outstanding (Diluted Average).
• The sharpest annual moves came in 2022 and 2023: Shares Outstanding (Diluted Average) climbed 1.7% in 2022, then fell 1.45% in 2023.
• A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $5.7 billion in 2022, then decreased by 0.42% to $5.7 billion in 2023, then decreased by 0.16% to $5.7 billion in 2024, then increased by 0.23% to $5.7 billion in 2025, then climbed by 0.32% to $5.7 billion in 2026.
• Business Quant data shows PFE's Shares Outstanding (Diluted Average) at $5.7 billion in Q1 2026, $5.7 billion in Q4 2025, and $5.7 billion in Q3 2025.